TOP TIERMARKET NEWSWIRE
Movers explained · 2026-11-19

Archived explainer. For the current picture see today's INSM page.

Why Is INSMED INC (INSM) Stock Up Today?

By the Top Tier Newswire AI Desk · November 19, 2026 at 12:21 PM ET · reviewed against 15 wire stories

INSMED INC (INSM) is up +18.40% in the latest session. Our newswire has captured 15 stories on INSM across 8 sources in the last 36 hours, with AI sentiment reading bullish (avg 67/100).

Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.

Insmed (INSM) shares surged 18.40% to close at $141.84, driven by reports that Sanofi is exploring a potential acquisition of the biopharmaceutical company. The stock opened at $119.45 and reached an intraday high of $149.07 at 10:15 AM ET before settling near the upper end of the range. Trading volume reached 8.2 million shares, representing 2.9 times the three-month daily average.

What Happened

Sanofi is currently consulting with advisers and evaluating a potential deal to acquire Insmed, according to sources familiar with the matter. This development marks a significant shift for the company, which had already been experiencing upward momentum. Prior to this news, the stock had gained 3.2% over the previous eight sessions, moving from $116.10 to $119.80. The acquisition speculation arrived alongside an update on the company’s ongoing clinical study, the INSPIRE AT longitudinal study, which provided an early signal for its pediatric rare-disease pipeline.

What The Data Shows

The market capitalization of Insmed stands at $26.7 billion, with the company currently unprofitable and reporting a trailing twelve-month earnings per share of negative $2.80. Despite the lack of profitability, revenue growth has been robust at 240.0% on a trailing twelve-month basis, though the net margin remains negative at 39.9%. The stock’s beta is 0.81, indicating lower volatility relative to the broader market. The 52-week range spans from $90.39 to $212.75, and the recent move contributed to 12 fresh 52-week highs recorded on November 19, 2026.

Insider activity shows one sale totaling $3.1 million in the last 90 days, with the most recent filing dated September 11, 2026. Director David R. Brennan sold shares on September 9, 2026. Congressional disclosures indicate Donald J. Trump bought between $15,001 and $50,000 on July 17, 2026, and sold between $1,001 and $15,000 on June 16, 2026. Retail sentiment has improved, with the seven-day average rising to 65 out of 100 from a 30-day average of 59.

What To Watch

Market participants will monitor further developments regarding the Sanofi acquisition talks and any official statements from either company. Additionally, the breadth of analyst coverage, which currently includes 15 stories from eight sources in the last 36 hours, suggests heightened scrutiny on the company’s valuation and strategic direction.

AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.

INSM by the numbers

Last: $141.84Session: +18.40%7 sessions: +20.90%Coverage: 15 stories / 8 sourcesAI sentiment: 67/100 (bullish)Mkt cap: $26.7B52w: $90.39 to $212.75
INSM · Nov 19 session (5-min) · +20.43% vs prior close · updated 6:57 PM ET
$118$133$148prev close $119.80$144.287:15 AM10:06 AM12:57 PM3:48 PM6:40 PM7:15 AM · $119.457:25 AM · $120.508:00 AM · $119.758:20 AM · $119.759:30 AM · $119.979:35 AM · $120.729:40 AM · $120.639:45 AM · $120.239:50 AM · $121.339:55 AM · $121.2910:00 AM · $128.0310:05 AM · $128.0310:15 AM · $138.0610:20 AM · $138.0210:25 AM · $139.7010:30 AM · $137.6910:35 AM · $137.2910:40 AM · $137.4110:45 AM · $138.1910:50 AM · $139.0910:55 AM · $139.1211:00 AM · $140.4411:05 AM · $140.1511:10 AM · $140.2011:15 AM · $141.8211:20 AM · $142.0211:25 AM · $142.1911:30 AM · $144.4911:35 AM · $143.8711:40 AM · $143.8811:45 AM · $142.6711:50 AM · $142.1011:55 AM · $141.8812:00 PM · $140.9112:05 PM · $140.9612:10 PM · $141.0612:15 PM · $141.5212:20 PM · $143.2912:25 PM · $143.0012:30 PM · $142.8412:35 PM · $142.9612:40 PM · $142.4212:45 PM · $142.2212:50 PM · $142.5912:55 PM · $142.201:00 PM · $141.901:05 PM · $142.871:10 PM · $141.861:15 PM · $141.771:20 PM · $141.691:25 PM · $142.551:30 PM · $142.841:35 PM · $142.081:40 PM · $142.001:45 PM · $142.211:50 PM · $142.001:55 PM · $141.652:00 PM · $143.732:05 PM · $143.892:10 PM · $144.172:15 PM · $143.602:20 PM · $143.762:25 PM · $144.522:30 PM · $144.542:35 PM · $144.572:40 PM · $145.022:45 PM · $144.462:50 PM · $145.632:55 PM · $144.673:00 PM · $144.973:05 PM · $145.433:10 PM · $145.353:15 PM · $145.033:20 PM · $145.213:25 PM · $144.223:30 PM · $144.433:35 PM · $144.803:40 PM · $144.783:45 PM · $144.473:50 PM · $144.783:55 PM · $144.254:00 PM · $144.994:05 PM · $143.724:15 PM · $144.504:25 PM · $144.504:35 PM · $144.464:40 PM · $144.334:45 PM · $144.304:50 PM · $144.504:55 PM · $144.005:05 PM · $144.765:10 PM · $144.005:15 PM · $144.005:20 PM · $144.595:25 PM · $144.565:35 PM · $144.545:40 PM · $144.706:00 PM · $144.866:05 PM · $145.206:10 PM · $145.306:15 PM · $145.276:20 PM · $146.006:35 PM · $144.896:40 PM · $144.28
AI sentiment, last 36h · averaged over 15 stories · 67/100 bullish
AI sentiment 67/100 (bullish)0 · bearish50bullish · 100

The headlines behind the move

Story flow · 8 stories on the wire, last 36h · hover or tap a dot for the headline
36h ago24h ago12h agopublishThe Fly · sentiment 50 · Insmed Trading Resumes Thefly News 2The Fly · 50Insmed Trading Resumes Thefly News 2Investing.com Markets · sentiment 63 · Sanofi weighs takeover of US drugmaker Insmed, Bloomberg News reportsInvesting.com Markets · 63Sanofi weighs takeover of US drugmaker Insmed, Bloomberg News reportsGuruFocus · sentiment 78 · Insmed (INSM) Shares Surge 15% on Sanofi Acquisition TalksGuruFocus · 78Insmed (INSM) Shares Surge 15% on Sanofi Acquisition TalksGuruFocus · sentiment 63 · Sanofi (SNY) Explores Acquisition of Insmed, a $26.6B U.S. Biotech FirmGuruFocus · 63Sanofi (SNY) Explores Acquisition of Insmed, a $26.6B U.S. Biotech FirmBarron's · sentiment 78 · Insmed Stock Already Was Flying High. Sanofi Takeover Buzz Lights the Afterburners.Barron's · 78Insmed Stock Already Was Flying High. Sanofi Takeover Buzz Lights the Afterburners.TipRanks · sentiment 58 · Insmed’s New Pediatric Rare-Disease Study Offers an Early Pipeline SignalTipRanks · 58Insmed’s New Pediatric Rare-Disease Study Offers an Early Pipeline SignalThe Fly · sentiment 78 · Insmed rises 18.3%The Fly · 78Insmed rises 18.3%Stocktwits News · sentiment 74 · INSM Stock On Track For Best Day In Over 3 Months After Sanofi Buyout TalksStocktwits News · 74INSM Stock On Track For Best Day In Over 3 Months After Sanofi Buyout Talks
1d agoStocktwits NewsBULLISH 74M&A

INSM Stock On Track For Best Day In Over 3 Months After Sanofi Buyout Talks

Sanofi is talking to advisers and studying a potential deal for Insmed, Bloomberg reported, citing unnamed people familiar with the matter.

1d agoThe FlyBULLISH 78General

Insmed rises 18.3%

1d agoTipRanksBULLISH 58Product/PR

Insmed’s New Pediatric Rare-Disease Study Offers an Early Pipeline Signal

Insmed ($INSM) announced an update on their ongoing clinical study. Study Overview: Insmed’s INSPIRE AT study, officially titled “INSPIRE AT: Longitudinal Study Com...

1d agoBarron'sBULLISH 78M&A

Insmed Stock Already Was Flying High. Sanofi Takeover Buzz Lights the Afterburners.

Insmed stock jumps following a report saying Sanofi is eyeing a takeover of the biopharma company.

1d agoGuruFocusBULLISH 63M&A

Sanofi (SNY) Explores Acquisition of Insmed, a $26.6B U.S. Biotech Firm

1d agoGuruFocusBULLISH 78M&A

Insmed (INSM) Shares Surge 15% on Sanofi Acquisition Talks

1d agoInvesting.com MarketsBULLISH 63M&A

Sanofi weighs takeover of US drugmaker Insmed, Bloomberg News reports

Sanofi weighs takeover of US drugmaker Insmed, Bloomberg News reports

1d agoThe FlyNEUTRAL 50General

Insmed Trading Resumes Thefly News 2

Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →

More on INSM: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.

Earlier INSM move explainers: 2026-11-20 · 2026-11-19 · 2026-10-30 · 2026-10-29 · 2026-10-06 · 2026-10-05 · 2026-08-07 · 2026-08-06